The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Engineered immunostimulatory cells can convert PBMCs from chronic lymphocytic leukemia (CLL) patients into potent tumor killing immune cells.
 
Joshua W. Keegan
No Relationships to Disclose
 
Frank Borriello
No Relationships to Disclose
 
Stacey M. Fernandes
No Relationships to Disclose
 
Jennifer R. Brown
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Catapult Therapeutics; Dynamo Therapeutics; Janssen; Kite, a Gilead company; Lilly; Loxo/Lilly; MEI Pharma; Nextcea; Novartis; Pfizer; Pharmacyclics; Rigel; Rigel; Roche/Genentech; Sunesis Pharmaceuticals; TG Therapeutics
Research Funding - Gilead Sciences (Inst); Loxo/Lilly (Inst); SPARC (Inst); TG Therapeutics (Inst); Verastem (Inst)
 
James A. Lederer
No Relationships to Disclose